Dabigatran Etexilate Capsule, Coated Pellets
Product Images NDC 0904-7253
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dabigatran Etexilate (NDC 0904-7253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Dab-igatran-fi-3-2 (Dab Igatran Fi 3 2)
Dab-igatran-fi-4-1-2 (Dab Igatran Fi 4 1 2)
Dab-igatran-graph1-2 (Dab Igatran Graph1 2)
Dab-igatran-graph4-2 (Dab Igatran Graph4 2)
Dab-igatran-str (Dab Igatran Str)
Dabigatran-110mg-60cap-cart (Dabigatran 110mg 60cap Cart)
This is a description of medication containing Dabigatran Etexilate in capsule form. Each capsule contains 126.83 mg of Dabigatran Etexilate mesylate, which is equivalent to 110 mg of Dabigatran Etexilate. The usual dosage instructions are included in the package insert. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is important to store the medication in its original package to protect it from moisture and keep it out of reach of children. The package contains 60 capsules and comes with an enclosed medication guide. The unit-dose package is not child-resistant and should be swallowed whole.*
Dabigatran-150mg-20cap-cart (Dabigatran 150mg 20cap Cart)
This text provides information about a medication called Dabigatran Etexilate in capsule form. Each capsule contains 150 mg of Dabigatran Etexilate. The package contains 20 capsules (2 x 10) and is meant for swallowing the whole capsule. It also states storage instructions between 20°C to 25°C with excursions permitted to 15°C to 30°C. The text emphasizes storing the medication in the original package to protect from moisture and keeping it out of reach of children. The medication guide enclosed in the unit of use container provides more details on dosage and usage instructions.*
Dabigatran-75mg-30cap-cart (Dabigatran 75mg 30cap Cart)
This is a description of Dabigatran Etexilate capsules in a unit dose packaging. Each capsule contains 86.48 mg of dabigatran etexilate mesylate equivalent to 75 mg of dabigatran etexilate. The usual dosage information can be found in the package insert. The medication should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) and should be protected from moisture. The packaging includes 30 capsules (3 x 10) and it is specified that the package is not child-resistant. The product is manufactured by Alkem Laboratories Ltd. in Mumbai, India, and distributed by Major Pharmaceuticals in Indianapolis, USA. Further information can be found at www.majorpharmaceuticals.com.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.